{"entity":{"type":"insider","cik":"0001824493","url":"/insider/0001824493","json_url":"/insider/0001824493.json","name":"Powell David Jonathan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":2,"first":"2020-11-25","last":"2020-12-01","span_basis":"filed_date"},"name_variants":[{"name":"Powell David Jonathan","source":"filing","n_filings":2,"first_seen":"2020-11-25","last_seen":"2020-12-01"}],"transactions":[{"id":3204703,"accession":"0000921895-20-003153","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000921895-20-003153","line_url":"/filing/0000921895-20-003153#line-5","is_derivative":false,"issuer_cik":"0001599298","issuer_name":"Summit Therapeutics Inc.","issuer_ticker":"SMMT","issuer_name_source":null,"issuer_url":"/issuer/0001599298","owner_cik":"0001824493","owner_name":"Powell David Jonathan","owner_display_name":"Powell David Jonathan","owner_url":"/insider/0001824493","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13713.0,"shares_display":"13,713","price_per_share":4.44,"price_display":"4.44","price_state":"stated","total_value":60885.72,"total_display":"60,885.72","total_whole":"60,886","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-30","filed_date":"2020-12-01","scope":"insider"},{"id":3204698,"accession":"0000921895-20-003153","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000921895-20-003153","line_url":"/filing/0000921895-20-003153#line-3","is_derivative":false,"issuer_cik":"0001599298","issuer_name":"Summit Therapeutics Inc.","issuer_ticker":"SMMT","issuer_name_source":null,"issuer_url":"/issuer/0001599298","owner_cik":"0001824493","owner_name":"Powell David Jonathan","owner_display_name":"Powell David Jonathan","owner_url":"/insider/0001824493","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29569.0,"shares_display":"29,569","price_per_share":4.39,"price_display":"4.39","price_state":"stated","total_value":129807.91,"total_display":"129,807.91","total_whole":"129,808","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-27","filed_date":"2020-12-01","scope":"insider"},{"id":2870860,"accession":"0001193805-20-001473","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193805-20-001473","line_url":"/filing/0001193805-20-001473#line-6","is_derivative":false,"issuer_cik":"0001599298","issuer_name":"Summit Therapeutics Inc.","issuer_ticker":"SMMT","issuer_name_source":null,"issuer_url":"/issuer/0001599298","owner_cik":"0001824493","owner_name":"Powell David Jonathan","owner_display_name":"Powell David Jonathan","owner_url":"/insider/0001824493","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12070.0,"shares_display":"12,070","price_per_share":4.32,"price_display":"4.32","price_state":"stated","total_value":52142.4,"total_display":"52,142.40","total_whole":"52,142","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-25","filed_date":"2020-11-25","scope":"insider"},{"id":2870851,"accession":"0001193805-20-001473","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193805-20-001473","line_url":"/filing/0001193805-20-001473#line-4","is_derivative":false,"issuer_cik":"0001599298","issuer_name":"Summit Therapeutics Inc.","issuer_ticker":"SMMT","issuer_name_source":null,"issuer_url":"/issuer/0001599298","owner_cik":"0001824493","owner_name":"Powell David Jonathan","owner_display_name":"Powell David Jonathan","owner_url":"/insider/0001824493","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11374.0,"shares_display":"11,374","price_per_share":4.21,"price_display":"4.21","price_state":"stated","total_value":47884.54,"total_display":"47,884.54","total_whole":"47,885","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-24","filed_date":"2020-11-25","scope":"insider"},{"id":2870845,"accession":"0001193805-20-001473","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-20-001473","line_url":"/filing/0001193805-20-001473#line-2","is_derivative":false,"issuer_cik":"0001599298","issuer_name":"Summit Therapeutics Inc.","issuer_ticker":"SMMT","issuer_name_source":null,"issuer_url":"/issuer/0001599298","owner_cik":"0001824493","owner_name":"Powell David Jonathan","owner_display_name":"Powell David Jonathan","owner_url":"/insider/0001824493","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6987.0,"shares_display":"6,987","price_per_share":4.4,"price_display":"4.40","price_state":"stated","total_value":30742.8,"total_display":"30,742.80","total_whole":"30,743","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-23","filed_date":"2020-11-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001599298","name":"Summit Therapeutics Inc.","url":"/issuer/0001599298","role":"Officer (Chief Scientific Officer)","n_filings":2,"first_seen":"2020-11-25","last_seen":"2020-12-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001824493","retrieved_at":"2026-08-24T05:33:54+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}